Applied DNA Sciences up 121% on advancement of coronavirus vaccine

This post was originally published on this site

Nano cap Applied DNA Sciences (APDN +121.1%) is the latest tiny company to enjoy a COVID-19-related pop. In this case, in response to its announcement that Italy’s Ministry of Health has signed off on a preclinical trial of a COVID-19 vaccine candidate (one of four) that the company is jointly developing with collaboration partner Takis Biotech.

Preliminary results should be available next month.

Source: dailystockbuzz

Leave a comment

Your email address will not be published. Required fields are marked *